STOCK TITAN

Recursion (NASDAQ: RXRX) director sells 40,000 shares in planned trade

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RECURSION PHARMACEUTICALS director Christopher Gibson converted and sold shares in a planned set of transactions. On May 22, 2026, he converted 40,000 shares of Class B Common Stock into 40,000 shares of Class A Common Stock, then sold those 40,000 Class A shares in an open-market transaction at $3.08 per share. The filing notes the activity was carried out under a Rule 10b5-1 trading plan adopted on May 12, 2025, indicating the trades were pre-scheduled. After these moves, he directly holds 883,735 Class A shares and 4,303,334 Class B shares, with each Class B share convertible into one Class A share.

Positive

  • None.

Negative

  • None.
Insider Gibson Christopher
Role null
Sold 40,000 shs ($123K)
Type Security Shares Price Value
Conversion Class B Common Stock 40,000 $0.00 --
Conversion Class A Common Stock 40,000 $0.00 --
Sale Class A Common Stock 40,000 $3.08 $123K
holding Class B Common Stock -- -- --
holding Class B Common Stock -- -- --
holding Class B Common Stock -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
Holdings After Transaction: Class B Common Stock — 4,303,334 shares (Direct, null); Class A Common Stock — 923,735 shares (Direct, null); Class B Common Stock — 0 shares (Indirect, by LAHWRAN-3 LLC); Stock Option (Right to Buy) — 0 shares (Direct, null)
Footnotes (1)
  1. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Shares sold 40,000 shares Class A Common Stock sold on May 22, 2026
Sale price $3.08 per share Average price for 40,000 Class A shares sold
Class A holdings after sale 883,735 shares Direct Class A Common Stock position after transactions
Class B holdings after conversion 4,303,334 shares Direct Class B Common Stock after converting 40,000 shares
Converted shares 40,000 shares Class B Common Stock converted into Class A Common Stock
Lowest option exercise price $2.48 per share Stock option on Class A Common Stock expiring December 30, 2030
Rule 10b5-1 trading plan financial
"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Class B Common Stock financial
"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person."
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
derivative conversion financial
"transaction_action": "derivative conversion""
Stock Option (Right to Buy financial
"security_title": "Stock Option (Right to Buy)""
automatic conversion financial
"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gibson Christopher

(Last)(First)(Middle)
C/O RECURSION PHARMACEUTICALS
41 S. RIO GRANDE STREET

(Street)
SALT LAKE CITY UTAH 84101

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RECURSION PHARMACEUTICALS, INC. [ RXRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock05/22/2026C(1)(2)40,000A$0923,735D
Class A Common Stock05/22/2026S(1)40,000D$3.08883,735D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock$0(3)05/22/2026C(1)(2)40,000 (3) (3)Class A Common Stock40,000$04,303,334D
Class B Common Stock$0 (3) (3)Class A Common Stock0386,000Iby LAHWRAN-3 LLC(4)
Class B Common Stock$0 (3) (3)Class A Common Stock0388,000Iby LAHWRAN-4 LLC(5)
Class B Common Stock$0 (3) (3)Class A Common Stock050,000Iby Gibson Family Trust(6)
Stock Option (Right to Buy)$7.25 (7)02/03/2035Class A Common Stock01,050,567D
Stock Option (Right to Buy)$10.09 (8)02/09/2034Class A Common Stock0666,898D
Stock Option (Right to Buy)$8.55 (9)02/01/2033Class A Common Stock0813,600D
Stock Option (Right to Buy)$11.4 (10)02/04/2032Class A Common Stock0399,002D
Stock Option (Right to Buy)$11.402/04/202202/04/2032Class A Common Stock05,436D
Stock Option (Right to Buy)$2.48 (11)12/30/2030Class A Common Stock0282,500D
Explanation of Responses:
1. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
2. Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock.
3. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
4. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
5. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
6. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
7. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
8. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
9. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
10. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
11. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Remarks:
/s/Jonathan Golightly, attorney-in-fact05/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did RXRX director Christopher Gibson report?

Gibson reported converting 40,000 Class B shares into 40,000 Class A shares, then selling 40,000 Class A shares at $3.08 each. These actions are recorded as a derivative conversion followed by an open-market sale on May 22, 2026.

Was the RXRX share sale by Christopher Gibson part of a trading plan?

Yes. The filing states the transaction was made under a Rule 10b5-1 trading plan adopted on May 12, 2025. Such plans pre-schedule trades, suggesting the timing reflects a pre-arranged program rather than a new, discretionary decision.

How many RXRX Class A shares does Christopher Gibson hold after the transactions?

Following the reported conversion and sale, Gibson directly holds 883,735 shares of Class A Common Stock. This figure reflects his position after selling 40,000 Class A shares that were created by converting an equal number of Class B shares.

What happened to Christopher Gibson’s Class B RXRX shares in this filing?

Gibson converted 40,000 Class B shares into Class A shares and then sold those Class A shares. After this conversion, he continues to hold 4,303,334 shares of Class B Common Stock, each convertible into one share of Class A Common Stock.

How large was Christopher Gibson’s RXRX stock sale in dollar terms?

Gibson sold 40,000 shares of Class A Common Stock at an average price of $3.08 per share. That implies total sale proceeds of roughly $123,200, based solely on the reported average transaction price and share count.

Does Christopher Gibson still have derivative or option positions tied to RXRX?

Yes. The filing lists several stock options (rights to buy Class A shares) with exercise prices ranging from $2.48 to $11.40 and expiration dates between 2030 and 2035, indicating ongoing derivative-based exposure.